XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue and Contract Liabilities
3 Months Ended
Mar. 31, 2025
Revenue and Contract Liabilities [Abstract]  
Revenue and Contract Liabilities

Note 2 — Revenue and Contract Liabilities

 

Revenue

 

The Company generates revenue in continuing operations from hemp-derived beverage sales.

 

For the three months ended March 31, 2025, all of the Company’s revenue from continuing operations is transferred at a point-in-time and relates to hemp-derived beverages. For the three months ended March 31, 2024, there was no revenue from continuing operations.

 

In accordance with ASC 606-10-50-13, the Company is required to include disclosure on its remaining performance obligations as of the end of the current reporting period. Due to the nature of the Company’s contracts, these reporting requirements are not applicable because the majority of the Company’s remaining contracts meet certain exemptions as defined in ASC 606-10-50-14 through 606-10-50-14A, including (i) performance obligation is part of a contract that has an original expected duration of one year or less and (ii) the right to invoice practical expedient.